# Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Study · id `cardio:ct-nct03298802` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03298802](<https://clinicaltrials.gov/study/NCT03298802>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03298802

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 453 participants.

## Technical summary

Registry record NCT03298802. Randomized; triple masking; primary purpose prevention. Start 2017-11-21 (actual); primary completion 2025-04-22 (actual). Results posted on 2026-06-24.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 453 participants (enrolled count; ClinicalTrials.gov record NCT03298802, source copy `cardio:ctgov-nct03298802-2026-07-14`, retrieved 2026-10-26)
- Started: 2017-11-21 (actual) (ClinicalTrials.gov record NCT03298802, source copy `cardio:ctgov-nct03298802-2026-07-14`, retrieved 2026-10-26)
- Primary completion: 2025-04-22 (actual) (ClinicalTrials.gov record NCT03298802, source copy `cardio:ctgov-nct03298802-2026-07-14`, retrieved 2026-10-26)
- Completion: 2025-04-22 (actual) (ClinicalTrials.gov record NCT03298802, source copy `cardio:ctgov-nct03298802-2026-07-14`, retrieved 2026-10-26)
- Results first posted: 2026-06-24 (ClinicalTrials.gov record NCT03298802, source copy `cardio:ctgov-nct03298802-2026-07-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03298802, source copy `cardio:ctgov-nct03298802-2026-07-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03298802-2026-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
- Condition: Pre-Eclampsia
- Condition: Gestational Hypertension
- Condition: Superimposed Pre-Eclampsia
- Condition: Hypertension, Pregnancy-Induced
- Condition: Postpartum Pregnancy-Induced Hypertension
- Condition: Postpartum Preeclampsia
- Intervention (Drug): Hydrochlorothiazide 50mg Tablet
- Intervention (Drug): Placebo Tablet
- Lead sponsor: The University of Texas Medical Branch, Galveston
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Hydrochlorothiazide (`cardio:hydrochlorothiazide`)
- Registry intervention is a member of this class by a sourced record link: Thiazide and thiazide-like diuretics (`cardio:thiazide-and-thiazide-like-diuretics`)

## Provenance

Content hash: 6fa1637bb2f11c2993f88625f3e5be6f6ff3a53021497b18bf0b7ae6ae3f9348
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
